Desicion to Buy. Entry Price = $301.60. Target Price=$307.60. Stop Price=$295.60.
$LLY one I am watching - holding up good and orange shade showing up on the chart indicating volatility contracting. Would like to see volume drying up here.
Same rational as always: strong up move, consolidation and reclaim of vwap - Target 356$
After a 60 day base and a 2T VCP from 11.75% to 5.85% LLY gives a low risk entry point @ 294.34. Will manage as 1/3 profit on 1R (Moving stop to break even), 2/3 profit at 2R and give the rest room for a higher move.
Same rational as always: Strong Up move - consolidation - reclaim of lower vwap band - let the show begin :) Target 313$
The PEAD projected a Bullish outlook for $LLY after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 66.67%.
Way overbought on all technicals, looking for a pullback to $270 range in the next week or so. Will add every $2 increase in stock price up. Will cover at or under target.
Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA |...
Eli Lilly and Company ( NYSE:LLY ) Sector: Health Technology (Pharmaceuticals: Major) Market Capitalization: $253.61B Current Price: $266.30 Breakout price: $270.95 (hold above) Buy Zone (Top/Bottom Range): $262.45-$247.10 Price Target: $308.00-$310.40 Estimated Duration to Target: 84-90d Contract of Interest: $LLY 6/17/22 300c Trade price as of publish date:...
The PEAD projected a Bullish outlook for $LLY after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 40%.
Strong positive recovery, INDEX +1296, share of portfolio 8%, stop loss = 236,4
LLY: Eli Lilly and Company 2022-02-24 16:00:00 US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
Short term and temporarily. Immediate targets 257, 263, 272. Invalidation 232. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and...
LLY forming a nice harmonic that i would like to see pull back don to the trendline in the rising wedge.lots of divergence on higher time frames. the move has already started so maybe look to try and see a pop to go back in short. Not financial advice
Price broke upper trendline of triangle on the 5th touch then a throwback occurred. Price is back in the symmetrical triangle again. Not quite to long entry level. This pattern is neutral until a trendline is broken with a trend in that direction. Todays candle at the moment I write this is a Doji, a candle of indecision If price breaks upward, then possible...
Eli Lilly and Company is Pharmaceutical company.. I see amazing buying opportunity, and great target by %36 up.
The stock broke through a good resistance level and is steadily moving higher. We expect growth up to $315 per share. Products of this company are in demand. ❤️ If you find this helpful and want more FREE forecasts in TradingView . . . . . Please show your support back, . . . . . . . . Hit the 👍 LIKE button, . . . . . . . . . . . Drop some feedback below in the...
LLY has provided a nice long opportunity with the recent break above the major trendline This breakout is comparable to a previous point, which led to a large megaphone price structure Price will likely stay above the trendline and climb within the megaphone (attempted to roughly sketch what it would look like)